Request for Covid-19 Impact Assessment of this Report
The United States Imatinib Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Imatinib Drugs market, reaching US$ million by the year 2028. As for the Europe Imatinib Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Imatinib Drugs players cover Apotex Inc., Novartis, Sanofi S.A., and Cipla Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Imatinib Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Capsules
Tablets
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Drug Stores
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Apotex Inc.
Novartis
Sanofi S.A.
Cipla Inc.
Mylan Pharms Inc.
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Imatinib Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Imatinib Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Imatinib Drugs by Country/Region, 2017, 2022 & 2028
2.2 Imatinib Drugs Segment by Type
2.2.1 Capsules
2.2.2 Tablets
2.3 Imatinib Drugs Sales by Type
2.3.1 Global Imatinib Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Imatinib Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Imatinib Drugs Sale Price by Type (2017-2022)
2.4 Imatinib Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Drug Stores
2.4.3 Others
2.5 Imatinib Drugs Sales by Application
2.5.1 Global Imatinib Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Imatinib Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Imatinib Drugs Sale Price by Application (2017-2022)
3 Global Imatinib Drugs by Company
3.1 Global Imatinib Drugs Breakdown Data by Company
3.1.1 Global Imatinib Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Imatinib Drugs Sales Market Share by Company (2020-2022)
3.2 Global Imatinib Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Imatinib Drugs Revenue by Company (2020-2022)
3.2.2 Global Imatinib Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Imatinib Drugs Sale Price by Company
3.4 Key Manufacturers Imatinib Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Imatinib Drugs Product Location Distribution
3.4.2 Players Imatinib Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Imatinib Drugs by Geographic Region
4.1 World Historic Imatinib Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Imatinib Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Imatinib Drugs Annual Revenue by Geographic Region
4.2 World Historic Imatinib Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Imatinib Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Imatinib Drugs Annual Revenue by Country/Region
4.3 Americas Imatinib Drugs Sales Growth
4.4 APAC Imatinib Drugs Sales Growth
4.5 Europe Imatinib Drugs Sales Growth
4.6 Middle East & Africa Imatinib Drugs Sales Growth
5 Americas
5.1 Americas Imatinib Drugs Sales by Country
5.1.1 Americas Imatinib Drugs Sales by Country (2017-2022)
5.1.2 Americas Imatinib Drugs Revenue by Country (2017-2022)
5.2 Americas Imatinib Drugs Sales by Type
5.3 Americas Imatinib Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Imatinib Drugs Sales by Region
6.1.1 APAC Imatinib Drugs Sales by Region (2017-2022)
6.1.2 APAC Imatinib Drugs Revenue by Region (2017-2022)
6.2 APAC Imatinib Drugs Sales by Type
6.3 APAC Imatinib Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Imatinib Drugs by Country
7.1.1 Europe Imatinib Drugs Sales by Country (2017-2022)
7.1.2 Europe Imatinib Drugs Revenue by Country (2017-2022)
7.2 Europe Imatinib Drugs Sales by Type
7.3 Europe Imatinib Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Imatinib Drugs by Country
8.1.1 Middle East & Africa Imatinib Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Imatinib Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Imatinib Drugs Sales by Type
8.3 Middle East & Africa Imatinib Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Imatinib Drugs
10.3 Manufacturing Process Analysis of Imatinib Drugs
10.4 Industry Chain Structure of Imatinib Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Imatinib Drugs Distributors
11.3 Imatinib Drugs Customer
12 World Forecast Review for Imatinib Drugs by Geographic Region
12.1 Global Imatinib Drugs Market Size Forecast by Region
12.1.1 Global Imatinib Drugs Forecast by Region (2023-2028)
12.1.2 Global Imatinib Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Imatinib Drugs Forecast by Type
12.7 Global Imatinib Drugs Forecast by Application
13 Key Players Analysis
13.1 Apotex Inc.
13.1.1 Apotex Inc. Company Information
13.1.2 Apotex Inc. Imatinib Drugs Product Offered
13.1.3 Apotex Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Apotex Inc. Main Business Overview
13.1.5 Apotex Inc. Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Imatinib Drugs Product Offered
13.2.3 Novartis Imatinib Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Sanofi S.A.
13.3.1 Sanofi S.A. Company Information
13.3.2 Sanofi S.A. Imatinib Drugs Product Offered
13.3.3 Sanofi S.A. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi S.A. Main Business Overview
13.3.5 Sanofi S.A. Latest Developments
13.4 Cipla Inc.
13.4.1 Cipla Inc. Company Information
13.4.2 Cipla Inc. Imatinib Drugs Product Offered
13.4.3 Cipla Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Cipla Inc. Main Business Overview
13.4.5 Cipla Inc. Latest Developments
13.5 Mylan Pharms Inc.
13.5.1 Mylan Pharms Inc. Company Information
13.5.2 Mylan Pharms Inc. Imatinib Drugs Product Offered
13.5.3 Mylan Pharms Inc. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mylan Pharms Inc. Main Business Overview
13.5.5 Mylan Pharms Inc. Latest Developments
13.6 Glenmark Pharmaceuticals Ltd.
13.6.1 Glenmark Pharmaceuticals Ltd. Company Information
13.6.2 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product Offered
13.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Glenmark Pharmaceuticals Ltd. Main Business Overview
13.6.5 Glenmark Pharmaceuticals Ltd. Latest Developments
13.7 Sun Pharmaceuticals
13.7.1 Sun Pharmaceuticals Company Information
13.7.2 Sun Pharmaceuticals Imatinib Drugs Product Offered
13.7.3 Sun Pharmaceuticals Imatinib Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sun Pharmaceuticals Main Business Overview
13.7.5 Sun Pharmaceuticals Latest Developments
13.8 Actavis Generics
13.8.1 Actavis Generics Company Information
13.8.2 Actavis Generics Imatinib Drugs Product Offered
13.8.3 Actavis Generics Imatinib Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Actavis Generics Main Business Overview
13.8.5 Actavis Generics Latest Developments
13.9 Dr. Reddy's Laboratories
13.9.1 Dr. Reddy's Laboratories Company Information
13.9.2 Dr. Reddy's Laboratories Imatinib Drugs Product Offered
13.9.3 Dr. Reddy's Laboratories Imatinib Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Dr. Reddy's Laboratories Main Business Overview
13.9.5 Dr. Reddy's Laboratories Latest Developments
13.10 Teva Pharmaceutical Industries Ltd.
13.10.1 Teva Pharmaceutical Industries Ltd. Company Information
13.10.2 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product Offered
13.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.10.5 Teva Pharmaceutical Industries Ltd. Latest Developments
14 Research Findings and Conclusion
Table 1. Imatinib Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Imatinib Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Capsules
Table 4. Major Players of Tablets
Table 5. Global Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 6. Global Imatinib Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Imatinib Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Imatinib Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Imatinib Drugs Sale Price by Type (2017-2022) & (USD/MT)
Table 10. Global Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 11. Global Imatinib Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Imatinib Drugs Revenue by Application (2017-2022)
Table 13. Global Imatinib Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Imatinib Drugs Sale Price by Application (2017-2022) & (USD/MT)
Table 15. Global Imatinib Drugs Sales by Company (2020-2022) & (K MT)
Table 16. Global Imatinib Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Imatinib Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Imatinib Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Imatinib Drugs Sale Price by Company (2020-2022) & (USD/MT)
Table 20. Key Manufacturers Imatinib Drugs Producing Area Distribution and Sales Area
Table 21. Players Imatinib Drugs Products Offered
Table 22. Imatinib Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Imatinib Drugs Sales by Geographic Region (2017-2022) & (K MT)
Table 26. Global Imatinib Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Imatinib Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Imatinib Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Imatinib Drugs Sales by Country/Region (2017-2022) & (K MT)
Table 30. Global Imatinib Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Imatinib Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Imatinib Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Imatinib Drugs Sales by Country (2017-2022) & (K MT)
Table 34. Americas Imatinib Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Imatinib Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Imatinib Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 38. Americas Imatinib Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 40. Americas Imatinib Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Imatinib Drugs Sales by Region (2017-2022) & (K MT)
Table 42. APAC Imatinib Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Imatinib Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Imatinib Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 46. APAC Imatinib Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 48. APAC Imatinib Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Imatinib Drugs Sales by Country (2017-2022) & (K MT)
Table 50. Europe Imatinib Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Imatinib Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Imatinib Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 54. Europe Imatinib Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 56. Europe Imatinib Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Imatinib Drugs Sales by Country (2017-2022) & (K MT)
Table 58. Middle East & Africa Imatinib Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Imatinib Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Imatinib Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Imatinib Drugs Sales by Type (2017-2022) & (K MT)
Table 62. Middle East & Africa Imatinib Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Imatinib Drugs Sales by Application (2017-2022) & (K MT)
Table 64. Middle East & Africa Imatinib Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Imatinib Drugs
Table 66. Key Market Challenges & Risks of Imatinib Drugs
Table 67. Key Industry Trends of Imatinib Drugs
Table 68. Imatinib Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Imatinib Drugs Distributors List
Table 71. Imatinib Drugs Customer List
Table 72. Global Imatinib Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 73. Global Imatinib Drugs Sales Market Forecast by Region
Table 74. Global Imatinib Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Imatinib Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Imatinib Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 77. Americas Imatinib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Imatinib Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 79. APAC Imatinib Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Imatinib Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 81. Europe Imatinib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Imatinib Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 83. Middle East & Africa Imatinib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Imatinib Drugs Sales Forecast by Type (2023-2028) & (K MT)
Table 85. Global Imatinib Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Imatinib Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Imatinib Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Imatinib Drugs Sales Forecast by Application (2023-2028) & (K MT)
Table 89. Global Imatinib Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Imatinib Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Imatinib Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. Apotex Inc. Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Apotex Inc. Imatinib Drugs Product Offered
Table 94. Apotex Inc. Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 95. Apotex Inc. Main Business
Table 96. Apotex Inc. Latest Developments
Table 97. Novartis Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Novartis Imatinib Drugs Product Offered
Table 99. Novartis Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 100. Novartis Main Business
Table 101. Novartis Latest Developments
Table 102. Sanofi S.A. Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi S.A. Imatinib Drugs Product Offered
Table 104. Sanofi S.A. Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 105. Sanofi S.A. Main Business
Table 106. Sanofi S.A. Latest Developments
Table 107. Cipla Inc. Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Cipla Inc. Imatinib Drugs Product Offered
Table 109. Cipla Inc. Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 110. Cipla Inc. Main Business
Table 111. Cipla Inc. Latest Developments
Table 112. Mylan Pharms Inc. Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Mylan Pharms Inc. Imatinib Drugs Product Offered
Table 114. Mylan Pharms Inc. Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 115. Mylan Pharms Inc. Main Business
Table 116. Mylan Pharms Inc. Latest Developments
Table 117. Glenmark Pharmaceuticals Ltd. Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product Offered
Table 119. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 120. Glenmark Pharmaceuticals Ltd. Main Business
Table 121. Glenmark Pharmaceuticals Ltd. Latest Developments
Table 122. Sun Pharmaceuticals Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Sun Pharmaceuticals Imatinib Drugs Product Offered
Table 124. Sun Pharmaceuticals Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 125. Sun Pharmaceuticals Main Business
Table 126. Sun Pharmaceuticals Latest Developments
Table 127. Actavis Generics Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Actavis Generics Imatinib Drugs Product Offered
Table 129. Actavis Generics Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 130. Actavis Generics Main Business
Table 131. Actavis Generics Latest Developments
Table 132. Dr. Reddy's Laboratories Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Dr. Reddy's Laboratories Imatinib Drugs Product Offered
Table 134. Dr. Reddy's Laboratories Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 135. Dr. Reddy's Laboratories Main Business
Table 136. Dr. Reddy's Laboratories Latest Developments
Table 137. Teva Pharmaceutical Industries Ltd. Basic Information, Imatinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product Offered
Table 139. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 140. Teva Pharmaceutical Industries Ltd. Main Business
Table 141. Teva Pharmaceutical Industries Ltd. Latest Developments
List of Figures
Figure 1. Picture of Imatinib Drugs
Figure 2. Imatinib Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Imatinib Drugs Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Imatinib Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Imatinib Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Capsules
Figure 10. Product Picture of Tablets
Figure 11. Global Imatinib Drugs Sales Market Share by Type in 2021
Figure 12. Global Imatinib Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Imatinib Drugs Consumed in Hospitals
Figure 14. Global Imatinib Drugs Market: Hospitals (2017-2022) & (K MT)
Figure 15. Imatinib Drugs Consumed in Drug Stores
Figure 16. Global Imatinib Drugs Market: Drug Stores (2017-2022) & (K MT)
Figure 17. Imatinib Drugs Consumed in Others
Figure 18. Global Imatinib Drugs Market: Others (2017-2022) & (K MT)
Figure 19. Global Imatinib Drugs Sales Market Share by Application (2017-2022)
Figure 20. Global Imatinib Drugs Revenue Market Share by Application in 2021
Figure 21. Imatinib Drugs Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Imatinib Drugs Revenue Market Share by Company in 2021
Figure 23. Global Imatinib Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Imatinib Drugs Revenue Market Share by Geographic Region in 2021
Figure 25. Global Imatinib Drugs Sales Market Share by Region (2017-2022)
Figure 26. Global Imatinib Drugs Revenue Market Share by Country/Region in 2021
Figure 27. Americas Imatinib Drugs Sales 2017-2022 (K MT)
Figure 28. Americas Imatinib Drugs Revenue 2017-2022 ($ Millions)
Figure 29. APAC Imatinib Drugs Sales 2017-2022 (K MT)
Figure 30. APAC Imatinib Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Europe Imatinib Drugs Sales 2017-2022 (K MT)
Figure 32. Europe Imatinib Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Imatinib Drugs Sales 2017-2022 (K MT)
Figure 34. Middle East & Africa Imatinib Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Americas Imatinib Drugs Sales Market Share by Country in 2021
Figure 36. Americas Imatinib Drugs Revenue Market Share by Country in 2021
Figure 37. United States Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Imatinib Drugs Sales Market Share by Region in 2021
Figure 42. APAC Imatinib Drugs Revenue Market Share by Regions in 2021
Figure 43. China Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Imatinib Drugs Sales Market Share by Country in 2021
Figure 50. Europe Imatinib Drugs Revenue Market Share by Country in 2021
Figure 51. Germany Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Imatinib Drugs Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Imatinib Drugs Revenue Market Share by Country in 2021
Figure 58. Egypt Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Imatinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Imatinib Drugs in 2021
Figure 64. Manufacturing Process Analysis of Imatinib Drugs
Figure 65. Industry Chain Structure of Imatinib Drugs
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...